In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18650378

Proc. Natl. Acad. Sci. U.S.A. 2008 Jul 29 105 30 10547-52

Download in:

View as

Triples

General Info

PMID
18650378